Back to Parkinsons Disease
NCT02989610
NCT02989610
Who may be able to join
Who might be able to join this trial:
- You are able to give your own consent to take part in the study
- You have been diagnosed with Parkinson's disease and your doctor has recommended you receive, or you have already received, a specific type of deep brain stimulation (DBS) device called the Infinity system, with leads placed on both sides of a specific area of the brain (called the Subthalamic Nucleus)
- You are able to attend the required follow-up appointments during the study
Who may not be able to join:
- You are not considered a suitable candidate for surgery
- In the opinion of the study doctor, you would not be able to handle having multiple device programming sessions in a single visit
- You are unable to follow the required schedule of check-up appointments during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Abbott Medical Devices
Registry
clinicaltrials_gov
Start date
31 January 2017
Est. completion
7 August 2019
Where this trial is recruiting
🇦🇺 Australia
🇧🇪 Belgium
🇩🇪 Germany
🇮🇹 Italy
🇵🇱 Poland
🇪🇸 Spain
🇬🇧 United Kingdom
🇺🇸 United States
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage Of Participants With Wider Therapeutic Window With Directional Programming (Superiority)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.